India has approved Daiichi Sankyo’s stake purchase in the country’s top drug maker by sales, Ranbaxy Laboratories, the finance ministry said in a statement on Wednesday.Japan’s Daiichi has agreed to buy a 34.8 percent stake in Ranbaxy and aims to take up to 20 percent more from the open market in deals worth up to $4.6 billion.
The Japanese drug maker will also make an open offer to buy up to 20 percent of shares in another Indian firm, Zenotech Laboratories, which is 47-percent owned by Ranbaxy.
No comments:
Post a Comment